Table 1.

Suppression of KCC2-activity measured as shift in E_glycine by 0.5 mM furosemide across different nuclei and species.

	Mouse			Gerbil
	LSO	MSO	SPN	LSO	MSO	SPN
Control Eglycine	−68.6 ± 8.7 mV	−75.8 ± 15.7 mV	−90.6 ± 8.6 mV	−62.9 ± 4.9 mV	−67.4 ± 12.4 mV	−58.1 ± 3.03 mV
Furosemide Eglycine	−51.0 ± 8.2 mV	−52.2 ± 15.4 mV	−54.5 ± 14.3 mV	−47.0 ± 13.7 mV	−49.0 ± 12.8 mV	−36.4 ± 5.4 mV
Δ Eglycine	17.6 mV	23.6 mV	36.2 mV	15.9 mV	18.4 mV	21.7 mV
n	6	6	7	6	6	4
Significance	p = 0.037	p = 0.025	p ≤ 0.001	p = 0.035	p = 0.018	p = 0.014